CIK 0001534969
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
SERA PROGNOSTICS, INC.
Sign in to watch- Ticker
- SERA
- Exchange
- Nasdaq
- Industry
- Services-Medical Laboratories
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 261911522
- Phone
- +1 801-990-0520
- Business address
- 2749 E. PARLEYS WAY, SUITE 200, SALT LAKE CITY, UT, 84109
- Former names
- SERA PROGNOSTICS, INC.
- 4 Planned sale Director sold 1,560 shares at $3.05 ($4,758)
- 4 Open-market sale Director sold 292 shares at $3.05 ($891)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $2.93 ($5,860)
- 4 Open-market sale Chief Data Officer sold 32,203 shares at $2.94 ($94,677)
- 4 Planned sale Chief Data Officer sold 1,986 shares at $3.51 ($6,971)
- 4 Open-market sale Chief Executive Officer sold 11,594 shares at $2.62 ($30,376)
- 4 Open-market sale Chief Data Officer sold 7,073 shares at $2.62 ($18,531)
- 4 Open-market sale General Counsel sold 7,059 shares at $2.62 ($18,495)
- 4 Open-market sale Chief Information Officer sold 6,528 shares at $2.62 ($17,103)
- 4 Open-market sale Chief Scientific Officer sold 7,767 shares at $2.62 ($20,350)
- 4 Open-market sale Chief Financial Officer sold 6,351 shares at $2.62 ($16,640)
- 4 Open-market sale Director sold 221 shares at $3.04 ($672)
- 4 Planned sale Chief Information Officer sold 2,000 shares at $3.07 ($6,140)
- 4 Grant or award Chief Medical Officer acquired 75,000 shares (grant or award)
- 3 Insider Initial Statement of Ownership
- 4 Planned sale Chief Information Officer sold 2,000 shares at $3.18 ($6,360)
- 4 Open-market sale Director sold 227 shares at $3.16 ($717)
- 4 Open-market sale Chief Executive Officer sold 3,246 shares at $3.13 ($10,160)
- 4 Open-market sale Chief Data Officer sold 1,271 shares at $3.13 ($3,978)
- 4 Open-market sale General Counsel sold 934 shares at $3.13 ($2,923)
Page 4 of 16 · 313 filings